IBD Registry in a Sub-Saharan African Population
Registry to Study the Incidence, Phenotype, Risk Factors and Clinical Course of Inflammatory Bowel Disease in Zimbabwe
University of Zimbabwe
100 participants
Jan 2, 2021
OBSERVATIONAL
Conditions
Summary
The investigators intend to establish a prospective registry of patients diagnosed with inflammatory bowel disease at Parirenyatwa hospital in Harare, Zimbabwe. The study will periodically collect data on disease phenotype, disease course, and clinical management, and will biobank stool specimens and germline DNA. One relative, and an individual from the same neighbourhood will be also be recruited for a nested case-control study into risk factors of inflammatory bowel disease in this population.
Eligibility
Inclusion Criteria6
- Cases
- Any patient with confirmed inflammatory bowel disease
- Onset of disease ≥3 months ago.
- Controls
- Age ≥ 18 years (NB - cases younger than 18 will be excluded from case-control analysis
- One sibling or cousin (2nd degree) and one neighbourhood control.
Exclusion Criteria6
- Cases
- \. None
- Controls
- Suspected inflammatory bowel disease
- Unexplained gastrointestinal symptoms including diarrhoea, vomiting, chronic abdominal pain, weight loss, rectal bleeding, and recent change in bowel habit.
- Previous unexplained gastrointestinal surgery
Interventions
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04178408